← Browse by Condition
Medical Condition
tuberculosis
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 3, Phase 2, Phase 4
ClinicalMetric tracks all active clinical trials for tuberculosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — tuberculosis Clinical Trials
How many clinical trials are currently recruiting for tuberculosis?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for tuberculosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for tuberculosis?
tuberculosis research spans Phase 2 (1 trial), Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a tuberculosis clinical trial?
Eligibility criteria for tuberculosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 2
Phase 4 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07086820
Recruiting
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
Enrollment
647 pts
Location
Chile
Sponsor
Pontificia Universidad Catolic...
NCT05473520 Phase 3
Recruiting
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Enrollment
150 pts
Location
Malaysia, Singapore
Sponsor
National University Hospital, ...
NCT06033807
Recruiting
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Enrollment
31,440 pts
Location
China
Sponsor
Huashan Hospital
NCT06706596
Recruiting
A Systemic Screening for TB Disease in High-risk Groups in Barcelona
Enrollment
3,000 pts
Location
Spain
Sponsor
Fundació Institut Germans Tria...
NCT05656287
Recruiting
My Mobile Wallet: An Intervention for Tuberculosis Medication Adherence in Rural Uganda
Enrollment
242 pts
Location
Uganda
Sponsor
Mbarara University of Science ...
NCT06593080
Recruiting
The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis
Enrollment
30,240 pts
Location
Zambia
Sponsor
Chishala Chabala
NCT06748937 Phase 2
Recruiting
A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide
Enrollment
60 pts
Location
South Africa
Sponsor
TASK Applied Science
NCT06022146 Phase 3
Recruiting
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Enrollment
3,520 pts
Location
China
Sponsor
Huashan Hospital
NCT07484490
Recruiting
Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis
Enrollment
34 pts
Location
Pakistan
Sponsor
Riphah International Universit...
NCT06403943 Phase 4
Recruiting
Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis
Enrollment
292 pts
Location
China
Sponsor
Beijing Chest Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology